SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015254
Filing Date
2022-08-08
Accepted
2022-08-08 08:01:47
Documents
55
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cinc-20220630.htm   iXBRL 10-Q 2146323
2 EX-31.1 cinc-ex31_1.htm EX-31.1 18939
3 EX-31.2 cinc-ex31_2.htm EX-31.2 18992
4 EX-32.1 cinc-ex32_1.htm EX-32.1 22833
  Complete submission text file 0000950170-22-015254.txt   6955073

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cinc-20220630_cal.xml EX-101.CAL 32067
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cinc-20220630_pre.xml EX-101.PRE 284565
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cinc-20220630.xsd EX-101.SCH 42899
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cinc-20220630_def.xml EX-101.DEF 174319
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cinc-20220630_lab.xml EX-101.LAB 399273
49 EXTRACTED XBRL INSTANCE DOCUMENT cinc-20220630_htm.xml XML 1124281
Mailing Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451
Business Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451 8445311834
CinCor Pharma, Inc. (Filer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41201 | Film No.: 221142610
SIC: 2834 Pharmaceutical Preparations